美国食品药品监督管理局局长对特朗普第二任期内可能发生的领导和政策变化表示担忧. FDA chief expresses concern over potential leadership and policy changes under Trump's second term.

林业发展局专员Robert Califf对当选总统特朗普第二任任期的变动表示不确定,暗示领导和政策可能发生转变。 FDA Commissioner Robert Califf expressed uncertainty about changes under President-elect Trump's second term, hinting at potential shifts in leadership and policy. Trump承诺在公共卫生决策中让怀疑疫苗的Robert F Kennedy Jr在公共卫生决策中发挥重大作用,这可能会扰乱该机构。 Trump has promised a significant role for vaccine skeptic Robert F Kennedy Jr in public health decisions, which could disrupt the agency. Califf希望,知识丰富的工作人员将留下来,确保公共卫生福利。 Califf hopes that knowledgeable staff will remain to ensure public health welfare.